Cargando…

Combination of platelet-to-lymphocyte ratio and D-dimer for the identification of cardiogenic cerebral embolism in non-valvular atrial fibrillation

BACKGROUND: Non-valvular atrial fibrillation (NVAF) is the most common cause of cardiogenic cerebral embolism (CCE). However, the underlying mechanism between cerebral embolism and NVAF is indefinite, and there is no effective and convenient biomarker to identify potential risk of CCE in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yachen, Xuan, Chenhao, Ji, Wei, Wang, Feng, Huang, Jin, Li, Lei, Wang, Hui, Deng, Jingyu, Shao, Junfei, Chen, Kefei, Mao, Xuqiang, Xu, Qinghua, You, Yiping, Xi, Guangjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945082/ https://www.ncbi.nlm.nih.gov/pubmed/36846117 http://dx.doi.org/10.3389/fneur.2023.1069261

Ejemplares similares

A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
por: Song, Ziliang, et al.
Publicado: (2020)

Potential of brain age in identifying early cognitive impairment in subcortical small-vessel disease patients
por: Shi, Yachen, et al.
Publicado: (2022)

Mean Platelet Volume to Platelet Count Ratio Predicts Left Atrial Stasis in Patients with Non-Valvular Atrial Fibrillation
por: Liu, Xiaoyan, et al.
Publicado: (2023)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
por: Wang, Jiayu, et al.
Publicado: (2019)

Transesophageal Echocardiography in Cardiogenic Embolic Cerebral Infarction
por: Chu, Wen, et al.
Publicado: (2018)

Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation
por: Wang, Hua, et al.
Publicado: (2022)

Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation have a Risk for Aortogenic Embolizations
por: Kojima, Keisuke, et al.
Publicado: (2021)

Percutaneous Coil Embolization of Coronary Artery Fistula Complicated by Refractory Ventricular Fibrillation and Cardiogenic Shock
por: Akhtar, Ahmad, et al.
Publicado: (2022)

Prognostic biomarkers in COVID-19 infection: value of anemia, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer
por: Hashem, Maiada K., et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism
por: Phan, Trung, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios in those with Pulmonary Embolism in the Course of Coronavirus Disease 2019
por: Akkus, Canan, et al.
Publicado: (2021)

Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
por: Hamatani, Yasuhiro, et al.
Publicado: (2016)

Response to “Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation have a Risk for Aortogenic Embolizations”
por: Suzuki, Masayuki, et al.
Publicado: (2021)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation
por: Providência, Rui, et al.
Publicado: (2013)

Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke
por: Paulin, Bilonda K., et al.
Publicado: (2019)

Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
por: Chen, Jian-Qin, et al.
Publicado: (2023)

Early neurological deterioration in cardiogenic cerebral embolism due to nonvalvular atrial fibrillation: Predisposing factors and clinical implications
por: Cong, Lin, et al.
Publicado: (2020)

The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism
por: Ma, Yaqing, et al.
Publicado: (2016)

SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S(4)-BOW-AF)
por: Harris, Daniel E, et al.
Publicado: (2023)

Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios Are Associated with Recurrent Ischemic Stroke in Patients with Embolic Stroke of Undetermined Source
por: Li, Tony Y.W., et al.
Publicado: (2022)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy
por: Lenart-Migdalska, Aleksandra, et al.
Publicado: (2021)

Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation
por: Alberts, Mark, et al.
Publicado: (2023)

Prognostic Value of Neutrophil-Lymphocyte Ratio in Cardiogenic Shock: A Cohort Study
por: Peng, Yangpei, et al.
Publicado: (2020)

Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya
por: Temu, Tecla M., et al.
Publicado: (2017)

The clinical value of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer-to-fibrinogen ratio for predicting pneumonia and poor outcomes in patients with acute intracerebral hemorrhage
por: Luo, Sai, et al.
Publicado: (2022)

Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation: Sub-analysis of the EXPAND Study
por: Uchiyama, Shinichiro, et al.
Publicado: (2018)

Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA(2)DS(2)‐VASc score of 0
por: Choi, Hyohun, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

Valvular Disease of Heart with Embolism of the Cerebral and Posterior Tibial Arteries
por: Poynder, G. F.
Publicado: (1882)

Prevalence of Valvular and Non-valvular Atrial Fibrillation and the Application of Antithrombotic Treatment in a Tertiary Care Hospital
por: Dhungana, Sahadeb Prasad, et al.
Publicado: (2020)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
por: Ahmad, Saad, et al.
Publicado: (2016)

Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
por: Shi, Yachen, et al.
Publicado: (2023)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

No Histological Difference between Large Atherosclerotic and Cardiogenic Embolic Thrombus
por: Chen, Rui, et al.
Publicado: (2022)

Combination of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with plasma D-dimer level to improve the diagnosis of deep venous thrombosis (DVT) following ankle fracture
por: Gao, Zhida, et al.
Publicado: (2023)

Value of Preoperative Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Predicting Postoperative Atrial Fibrillation in Patients Undergoing Lung Resection
por: Sivri, Fatih, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t61rcjbpu5cdnren56rireee55